(Q44719653)

English

Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2). (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

G protein-coupled receptor

0 references

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Edward J Goetzl

6

object named as

Edward J Goetzl

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

author name string

Mei-Chuan Huang

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Che-Chung Yeh

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Yvonne Kong

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Charles J Zaloudek

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

122-129

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206986

0 references

Serum lysophosphatidic acid is produced through diverse phospholipase pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

21 January 2018

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

21 January 2018

Biochemical regulation of breast cancer cell expression of S1P2 (Edg-5) and S1P3 (Edg-3) G protein-coupled receptors for sphingosine 1-phosphate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

21 January 2018

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

21 January 2018

Simplified mammalian DNA isolation procedure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

21 January 2018

Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

21 January 2018

Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg Family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

21 January 2018

Lysophosphatidic acid stimulates phospholipase D activity and cell proliferation in PC-3 human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

21 January 2018

The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

21 January 2018

Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

21 January 2018

Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

21 January 2018

Different effects of glucose starvation on expression and stability of VEGF mRNA isoforms in murine ovarian cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

21 January 2018

Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

21 January 2018

Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

7 January 2021

based on heuristic

inferred from DOI database lookup

International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

7 January 2021

based on heuristic

inferred from DOI database lookup

Lysophosphatidic acid is a bioactive mediator in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

7 January 2021

based on heuristic

inferred from DOI database lookup

Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

7 January 2021

based on heuristic

inferred from DOI database lookup

Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

7 January 2021

based on heuristic

inferred from DOI database lookup

Lysophospholipid mediators of immunity and neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

7 January 2021

based on heuristic

inferred from DOI database lookup

Lysophospholipids in the limelight: autotaxin takes center stage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular endothelial growth factor (VEGF) and its receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

7 January 2021

based on heuristic

inferred from DOI database lookup

Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

7 January 2021

based on heuristic

inferred from DOI database lookup

VEGF, VEGFR-1, VEGFR-2, microvessel density and endothelial cell proliferation in tumours of the ovary

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

7 January 2021

based on heuristic

inferred from DOI database lookup

Physiological and pathophysiological roles of lysophosphatidic acids produced by secretory lysophospholipase D in body fluids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

7 January 2021

based on heuristic

inferred from DOI database lookup

Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

7 January 2021

based on heuristic

inferred from DOI database lookup

Role for 18:1 lysophosphatidic acid as an autocrine mediator in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

7 January 2021

based on heuristic

inferred from DOI database lookup

Unfolding the pathophysiological role of bioactive lysophospholipids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

7 January 2021

based on heuristic

inferred from DOI database lookup

Markedly elevated levels of vascular endothelial growth factor in malignant ascites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206986

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1206986

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44719653&oldid=1466317347"